|
Winning Product Launch Strategies: Maximizing sales from new pharmaceutical products
Maximizing sales from new pharmaceutical products
Use the case studies featured in this report to identify
successful product launch strategies…
With pharmaceutical R&D continuing to suffer from declining
productivity levels and stagnant returns on investment, effective,
flexible and commercially successful new product launches have
become more important than ever. How pharma companies drive
product uptake and the effectiveness of their competitive
positioning during the launch phase increasingly define
pharmaceutical market success.
Winning Product Launch Strategies is a new report featuring
case studies of successful product launches of several key drugs.
The results of 163 new product approvals and launches conducted
across the US and EU are analyzed to provide up-to-date
information on trends in new drug launches along with key factors
for successful launches.
Case studies include:
-
Eli Lilly: Alimta (pemetrexed)
-
Bristol-Myers Squibb: Reyataz (arazanavir)
-
Genentech/Roche: Avastin (bevacizumab)
Use this report to gain a comprehensive understanding of
current and future product launch strategies, discover key
differences between US and EU approaches and identify current best
practices for successful product launch.
View
Table Of Contents >
|
